Wednesday, September 6, 2006

Merck Report Absolves Managers on Vioxx

Article in today's Chicago Tribune -- Merck Report Absolves Managers on Vioxx, by Theresa Agovino:

    Merck & Co.'s board of directors said Wednesday that a 20-month investigation
    funded by the pharmaceutical company found that senior management acted
    responsibly in its development and marketing of its now withdrawn pain reliever Vioxx.

    The 1,700-page report, which cost $21 million, contained some minor criticisms of
    employee actions but concluded that "management acted with integrity and had
    legitimate reasons for making the decisions that it made, in light of the knowledge
    available at the time."

    Merck pulled Vioxx off the market two years ago after a study found it doubled patients'
    risk of heart attacks and strokes. The company now faces more than 14,200 lawsuits
    which allege Merck knew Vioxx's risk.

Vioxx | Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference Merck Report Absolves Managers on Vioxx:


Do you think this report will have any impact on the tort litigation? I have a hard time envisioning either side using it. If Merck was hoping that releasing the report would improve public image or litigation prospects, rather than being disregarded as self-serving, it may be telling that the stock price is down slightly today.

Posted by: Howard Erichson | Sep 7, 2006 8:02:46 AM


Give a break - oh, forgot FOSOMAX did break my bones. OH, wait bones heal, don't they? NO, not if one was taking vIOXX.

Has anyone really read this self piecing whatever it is? that Merck paid about $30M for?

Posted by: Dennis Harrison - MBA - BGS | Nov 18, 2008 7:28:14 PM

Post a comment